Venture Building Machine

We build ventures,
not just
deals

C&tech is a Basel-based venture builder operating across three integrated pillars: deal structuring & creation, R&D acceleration (therapeutics & diagnostics), and market expansion. We source, structure and scale independent companies across global healthcare markets — retaining equity and board involvement in every venture we create.

Venture builders. Research connectors. Market expanders.

5
Active geographies
EU · US · APAC · ME
3
Core pillars
deal · science · scale
360°
BD mandate
in / out · partner
CH
Headquartered
Basel, Switzerland
01 — Core

Three pillars

I
Deal Structuring & NewCo
Sourcing, structuring and creating independent ventures from healthcare deals. We source assets, design deal architecture, and build ventures with retained equity.
  • In/out licensing and deal architecture
  • Asset acquisition and IP structuring
  • JV and partnership design
  • Capital sourcing and fundraising strategy
  • Governance and board involvement
II
Science & R&D Collaboration
Connecting ventures with research institutions and capabilities for preclinical and clinical validation. We facilitate partnerships for POC generation and access to specialized research infrastructure.
  • Research institution partnerships for preclinical POC
  • Clinical collaboration and validation pathways
  • Access to tissue, organoid, and rare disease networks
  • Data generation and biomarker collaboration
  • Development-stage asset optimization
III
Market Expansion
Scaling validated solutions into new geographies through health system partnerships and commercial infrastructure.
  • Health system partnership development
  • Market entry and commercialisation
  • Commercial team building
  • Multi-geographic expansion
  • Local partnership structuring
02 — Model

How we operate

"Every asset has potential. Every partnership can scale. Every market needs the right architecture."
I
Source
Proprietary deal flow and partnership opportunities from a curated global network — intensive field presence across key healthcare hubs.
II
Structure
Assess scientific, commercial and regulatory merit. Design bespoke architecture — licensing, JV, acquisition, or partnership — for each opportunity.
III
Close
Coordinate diligence, lead negotiations and close deals. Establish venture governance and initial team structure.
IV
Scale
Build ventures or expand into new markets. Retain equity stakes and operational involvement in every company we create or expand.
02a — Pillar II

Science & R&D Collaboration

We facilitate access to leading research institutions globally — providing ventures with research capacity and capability including laboratory infrastructure, specialized equipment, and experienced scientific teams. Our partnerships enable preclinical and clinical proof-of-concept generation at scale. We connect ventures with capabilities — from early-stage R&D through development — accelerating timelines and reducing capital requirements.

02b — Pillar III

Market Expansion & Scaling

We scale validated solutions into new geographic markets by building commercial infrastructure, forging health system partnerships, and establishing local market presence. We work with pharmacy networks, NGOs, distributors, and key stakeholders across regions to create pathways for market entry and sustainable growth.

03 — Presence

Global network

Switzerland
Europe
United States
Asia-Pacific
Middle East
04 — Ventures

The NewCo engine

We don't just facilitate deals
We build companies

C&tech's core capability is transforming high-potential opportunities into independent, equity-generating ventures. We act as founding architects — assembling asset, capital, team and structure to create standalone businesses where we retain meaningful ownership and board involvement.

Proven commercial opportunity with defensible IP or market position
Clear regulatory pathway across target geographies identified
Strategic investor or capital partner committed to the vision
Management team assembled with domain expertise and track record
Funding strategy defined — seed through Series A at inception

C&tech can operate across all three pillars — from deal sourcing through R&D acceleration to market scaling — or focus on specific pillars based on client needs. Some ventures need full-cycle support from deal structure through market expansion. Others require only research collaboration to accelerate development, or market expansion expertise to enter new geographies. Our model is flexible to serve different client objectives and venture stages.

05 — Contact

Get in touch